Prior studies have demonstrated the safety and efficacy of the GnRH pump in patients with FHA [24–26] as an alternative to injectable gonadotropins, which are associated with risks of multifollicular ovulation, potentially resulting in multiple pregnancy and ovarian hyperstimulation syndrome (OHSS) [23]. The gene discussed is GNRH1; the disease is ovarian hyperstimulation syndrome.